Across TCGA pan-cancer cohorts, DEGS1 RNA is linked to patient survival in 25 of 34 cancer types, making it the most broadly survival-associated DEGS1 data layer compared with 2 for mutation status and 6 for mass-spec protein.
The strongest signal is observed in adrenocortical carcinoma (ACC), where higher DEGS1 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated DEGS1 expression acts as an unfavorable survival marker, although some lineages such as THCA and BRCA show a favorable association.
ACC, MESO, and KIRP are the cancer types where DEGS1 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.